| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.016 | 0.9 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.014 | 0.9 |